Cancer Research SABCS  Telomeres
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

[Cancer Research 59, 4222-4224, September 1, 1999]
© 1999 American Association for Cancer Research

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Daigo, Y.
Right arrow Articles by Nakamura, Y.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Daigo, Y.
Right arrow Articles by Nakamura, Y.
[Cancer Research 59, 4222-4224, September 1, 1999]
© 1999 American Association for Cancer Research


Advances in Brief

Absence of Genetic Alteration at Codon 531 of the Human c-src Gene in 479 Advanced Colorectal Cancers from Japanese and Caucasian Patients1

Yataro Daigo, Yoichi Furukawa, Teru Kawasoe, Hideyuki Ishiguro, Manabu Fujita, Sachiko Sugai, Shoji Nakamori, Gerrit-Jan Liefers, Rob A. E. M. Tollenaar, Cornelis J. H. van de Velde and Yusuke Nakamura2

Laboratory of Molecular Medicine, Human Genome Center, Institute of Medical Science, The University of Tokyo, Minato, Tokyo 108-8639, Japan [Y. D., Y. F., T. K., H. I., M. F., Y. N.]; Japanese Foundation for Cancer Research, Toshima, Tokyo 170-8455, Japan [S. S.]; The Second Department of Surgery, Osaka University Medical School, Suita City, Osaka 565-0871, Japan [S. N.]; and Department of Surgery, Leiden University Medical Center, 2300 RC, Leiden, the Netherlands [G-J. L., R. A. E. M. T., C. J. H. v. d. V.]

Activation of c-src, a cellular human gene homologous in sequence to the v-src gene of Rous sarcoma virus, had been thought to play an important role in the progression of several types of human cancers, without having undergone any genetic changes. However, recently truncating mutations at codon 531 of the c-src gene were reported in 12% of the advanced colon cancers, and it was also demonstrated that this change was activating, transforming, tumorigenic, and metastasis promoting. To investigate whether the codon 531-specific mutation could be involved in the carcinogenesis of colorectal cancer in the Japanese and Caucasian populations, we examined a total of 479 advanced colorectal cancers from 421 Japanese patients (46 of them with liver or lung metastases) and from 58 Caucasian patients (11 of them with liver metastases). Using the PCR-RFLP assay and additional single-strand conformation polymorphism analysis, we detected no genetic alteration in any of the advanced colorectal cancers. Our results suggest that the codon 531-specific mutational activation of c-src is unlikely to play a significant role in the malignant progression of colorectal cancers among most Japanese and Caucasian patients.




This article has been cited by other articles:


Home page
FASEB J.Home page
A. Spreafico, S. Schenone, T. Serchi, M. Orlandini, A. Angelucci, D. Magrini, G. Bernardini, G. Collodel, A. Di Stefano, C. Tintori, et al.
Antiproliferative and proapoptotic activities of new pyrazolo[3,4-d]pyrimidine derivative Src kinase inhibitors in human osteosarcoma cells
FASEB J, May 1, 2008; 22(5): 1560 - 1571.
[Abstract] [Full Text] [PDF]


Home page
Ann OncolHome page
K. Fizazi
The role of Src in prostate cancer
Ann. Onc., November 1, 2007; 18(11): 1765 - 1773.
[Abstract] [Full Text] [PDF]


Home page
CarcinogenesisHome page
K. Honda, T. Sakaguchi, K. Sakai, C. Schmedt, A. Ramirez, J. L. Jorcano, A. Tarakhovsky, H. Kamisoyama, and T. Sakai
Epidermal hyperplasia and papillomatosis in mice with a keratinocyte-restricted deletion of csk
Carcinogenesis, October 1, 2007; 28(10): 2074 - 2081.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
S. Huveneers, I. van den Bout, P. Sonneveld, A. Sancho, A. Sonnenberg, and E. H.J. Danen
Integrin {alpha}v{beta}3 Controls Activity and Oncogenic Potential of Primed c-Src
Cancer Res., March 15, 2007; 67(6): 2693 - 2700.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
W. Li, C. Marshall, L. Mei, J. Gelfand, and J. T. Seykora
Srcasm Corrects Fyn-induced Epidermal Hyperplasia by Kinase Down-regulation
J. Biol. Chem., January 12, 2007; 282(2): 1161 - 1169.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. M. L. Coluccia, D. Benati, H. Dekhil, A. De Filippo, C. Lan, and C. Gambacorti-Passerini
SKI-606 Decreases Growth and Motility of Colorectal Cancer Cells by Preventing pp60(c-Src)-Dependent Tyrosine Phosphorylation of {beta}-Catenin and Its Nuclear Signaling
Cancer Res., February 15, 2006; 66(4): 2279 - 2286.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
V. G. Brunton, E. Avizienyte, V. J. Fincham, B. Serrels, C. A. Metcalf III, T. K. Sawyer, and M. C. Frame
Identification of Src-Specific Phosphorylation Site on Focal Adhesion Kinase: Dissection of the Role of Src SH2 and Catalytic Functions and Their Consequences for Tumor Cell Behavior
Cancer Res., February 15, 2005; 65(4): 1335 - 1342.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 1999 by the American Association for Cancer Research.